Search
for
Sort by
Research 241–270 of 1000+
- If Women Just had Their Hormones Back the Way they Were!
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- Beyond the Surface: Exploring the Mind-Skin Dynamics of Psychodermatology
- COMPREHENSIVE OVERVIEW ON THE PROBLEMS OF HAIR AND THE VARIOUS HERBAL APPROACHES TO TREAT THEM
- If women just had their hormones back the way they were! (for youthful feeling-balance your hormones!)
- The pathogenesis of alopecia areata
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Telogen Effluvium
- Lupus erythematosus: systemic and cutaneous manifestations
- Physiologic skin changes in pregnancy
- Congenital Adrenal Hyperplasia
- Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients.
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Alopecia areata: An update
- Finasteride Blocks the Reduction in Ictal Activity Produced by Exogenous Estrous Cyclicity
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- An Overview of Alopecias
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Nonclassic Congenital Adrenal Hyperplasia
- TOXIC EPIDERMAL NECROLYSIS
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Associations between transition‐specific stress experience, nocturnal decline in ambulatory blood pressure, and C‐reactive protein levels among transgender men
- Update on the dermatologic use of systemic glucocorticosteroids
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Psychocutaneous disease